Lurasidone (Lur)
Lurasidoneis an atypical antipsychotic also approved for the treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults when used alone or in combination with lithium or valproate. Lurasidone may be useful for treating the cognitive and memory deficits seen in schizophrenia. In animal studies, it reversed dizocilpine-induced learning and memory impairment and was found to be superior in doing this to all of the other antipsychotics examined, including risperidone, olanzapine, quetiapine, clozapine, aripiprazole, and haloperidol. Lurasidone has activity at several serotonin receptors that are involved in learning and memory, and unlike most other antipsychotics, lacks any anticholinergic effects (which are known to impair cognitive processes and memory).These properties may underlie its improved effectiveness in treating these symptoms relative to older agents.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Lurasidone (Lur) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Lurasidone (Lur) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Lurasidone (Lur) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Lurasidone (Lur) CLIA Kit Customized Service Offer
n/a ELISA Kit for Lurasidone (Lur) ELISA Kit Customized Service Offer